Doctors Hospital Conference Series: Lung Cancer Screening – Low Dose, High Rewards
Lung cancer is the leading cause of cancer deaths among men and women in the United States, accounting for 27% of all cancer deaths. Only 15% of lung cancers are diagnosed at the localized stage, resulting in a poor overall survival (five-year survival rate of 17%). Screening with yearly low-dose computed tomography scan decreased mortality in a randomized trial of patients with increased risk due to smoking. This activity will address the importance of effective screening programs aimed at early detection to address this important public health problem.
Hospitalists, Internists, Family Medicine Physicians, Critical Care Physicians, Surgeons, Anesthesiologists, Emergency Medicine Physicians, Pulmonologists, Infectious Disease Physicians, Nurses, Respiratory Therapists, Radiology Technicians and other interested healthcare providers.
- Explain the scope of the lung cancer problem in the United States
- Describe the results of extensive research in CT lung screening and recent policy changes.
- Implement best practices for lung cancer screening.
Juan Carlos Batlle, M.D.
Doctors, Homestead, South Miami and West Kendall
Juan Carlos Batlle, M.D. has indicated that he has no relevant financial relationships to disclose and that his discussion will not include mention of investigational or off-label usage.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Bureau of Radiation Control
- 1.00 Florida Board of Respiratory Therapy
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.